BioAge Labs (BIOA) EBIAT (2024 - 2025)
BioAge Labs (BIOA) has disclosed EBIAT for 2 consecutive years, with -$25.9 million as the latest value for Q4 2025.
- Quarterly EBIAT fell 22.78% to -$25.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$80.6 million through Dec 2025, down 13.35% year-over-year, with the annual reading at -$80.6 million for FY2025, 13.35% down from the prior year.
- EBIAT hit -$25.9 million in Q4 2025 for BioAge Labs, down from -$20.2 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of -$12.9 million in Q1 2025 to a low of -$25.9 million in Q4 2025.